Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

can also treat the second most common type – dementia with Lewy bodies (DLB). The treatment is a cholinesterase inhibitor (ChEI): it's already been used with DLB patients, but up until now it was ...

Gray stressed the effects are quite modest and only really effective at the really early stages of Alzheimer’s disease (and don’t work for vascular dementia ... as three months. The most commonly ...

Wall Street analysts say clinical trials suggest that Cobenfy is at least as effective as other blockbuster antipsychotics, ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

reaching US$131 billion in 2028 – not just because these drugs affect weight, but because by extension they alleviate a host of other health conditions. Most of us know that being too heavy is ...

Hallucinations are a common symptom of dementia ... hallucinations, and medication. Hallucinations are sensory experiences that seem real but actually are created in the mind in the absence of an ...

Cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy (CADASIL) is the most common hereditary subcortical vascular dementia. It is caused by the defective ...

Emerging drug therapies for dementia focus on Alzheimer's disease, the most common cause of dementia. Current experimental treatments tackle specific pathways in disease pathogenesis and are ...

According to a recent study published by the American Academy of Neurology, certain diabetes drugs may significantly lower the risk of diseases like dementia and Parkinson’s. The prime focus of the ...